EyePoint (EYPT) Cash from Operations (2010 - 2026)
EyePoint (EYPT) reported Cash from Operations of 80549000.0 for Q1 2026, down 51.64% on a YoY basis from 166547151.92 in Q1 2025, and down 23.83% sequentially from 65047000.0 in Q4 2025.
EyePoint (EYPT) Cash from Operations (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Cash from Operations data on file, last reported at 80549000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 51.64% year-over-year to 80549000.0; the trailing twelve-month figure through Mar 2026 stood at 267539000.0 (down 80.56% YoY), and the FY2025 full-year result was 240110000.0, down 90.22% from the prior year.
- Cash from Operations eased to 80549000.0 in Q1 2026, from 65047000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 57023000.0 in Q2 2023 to a low of 80549000.0 in Q1 2026.
- A 5-year average of 30000882.35 and a median of 23109000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations soared 398.19% in 2023 and tumbled 210.18% in 2025, its largest moves.
- Tracing EYPT's Cash from Operations over 5 years: stood at 12588000.0 in 2022, then plunged by 83.58% to 23109000.0 in 2023, then sank by 55.13% to 35849000.0 in 2024, then sank by 81.45% to 65047000.0 in 2025, then decreased by 23.83% to 80549000.0 in 2026.
- Business Quant data shows EYPT's Cash from Operations at 80549000.0 in Q1 2026, 65047000.0 in Q4 2025, and 59354000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -80.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.55 Mn |
| Mar 31, 2026 | -80.55 Mn |
| Dec 31, 2025 | -65.05 Mn |
| Dec 31, 2025 | -65.05 Mn |
| Sep 30, 2025 | -59.35 Mn |
| Sep 30, 2025 | -59.35 Mn |
| Jun 30, 2025 | -62.59 Mn |
| Jun 30, 2025 | -62.59 Mn |
| Mar 31, 2025 | -53.12 Mn |
| Mar 31, 2025 | -53.12 Mn |
| Dec 31, 2024 | -35.85 Mn |
| Dec 31, 2024 | -35.85 Mn |
| Sep 30, 2024 | -39.03 Mn |
| Sep 30, 2024 | -39.03 Mn |
| Jun 30, 2024 | -20.18 Mn |
| Jun 30, 2024 | -20.18 Mn |
| Mar 31, 2024 | -31.17 Mn |
| Mar 31, 2024 | -31.17 Mn |
| Dec 31, 2023 | -23.11 Mn |
| Dec 31, 2023 | -23.11 Mn |